The Scientist - Home

Skin cancers in horses and humans show genetic similarities, but the animals are less prone to some other cancers, offering a platform to compare disease risk.

A protein from Helicobacter pylori inhibits amyloid formation in both microbes and humans, offering new leads for antimicrobial and neurodegenerative disease therapies.

Some microbes happily thrive in unforgiving environments. An extremophile hunt is underway to leverage their resilience tactics, from medicine to space exploration.

In his 40-year epidemiology career, Ian Lipkin has done it all: from discovering 2,000 viruses to solving a nationwide SARS crisis.

David Hubel and Torsten Wiesel discovered how the cerebral cortex processes visual information. Their research won them the Nobel Prize and revolutionized our understanding of the brain.

Historically, researchers focused on the role of sperm characteristics in fertilization success, but now female factors and cooperative processes are gaining recognition.

The pink bollworm pest destroyed cotton crops in the US for a century. A collaborative biotechnology program helped stamp it out.

In an open letter, researchers and staff at the National Institutes of Health raise concerns over recent policy changes.

Can AI really replace scientists? Robin, an AI system, identified a potential drug for vision loss, but scientists are skeptical of full research automation.

An engineered antibody offers a promising approach in limiting ongoing cholera outbreaks.

An intense training load, such as running long distances, can temporarily suppress the immune system, which may render athletes susceptible to falling ill.

Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic.

Any microbe, new or known, could cause an infection outbreak at any time. Researchers gear up to preemptively fight this potential pathogen X.

Scientists have discovered that a lack of iron in pregnant mice can alter the sex development of embryos, challenging long-held beliefs about how sex is determined.

Scientists behind a world-first gene therapy reveal how they teamed up with experts across academia and industry to produce a drug from start to finish in just six months.

Exploring the interaction between sensory neurons and drug aversion can offer clues to the genetic basis of addiction.

Greater numbers of circulating stem cells increase the efficacy of in vivo gene therapy techniques, potentially reducing the price tag of lifesaving treatments.

Matteo Farinella sketched out a career in science illustration, making neuroscience research more accessible to the public.

Aggressive breast cancer can become unresponsive to monoclonal antibody treatment, but targeting tumor-resident bacteria may extend its effectiveness.

The Brazilian Reproducibility Initiative team could replicate less than half of regional research findings. How can scientists use these data to improve research replicability?